Intra-articular glucocorticoid injections and their effect on hypothalamic–pituitary–adrenal (HPA)-axis function

详细信息    查看全文

• 作者：Philip C. Johnston ; M. Cecilia Lansang ; Soumya Chatterjee ; Laurence Kennedy
• 关键词：Intra ; articular glucocorticoid injection ; Hypothalamic?pituitary–adrenal (HPA) axis ; Adrenal suppression ; Cushing syndrome ; Cortisol ; Triamcinolone (Kenalog) ; Methylprednisolone (Depo ; medrol)
• 刊名：Endocrine
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：48
• 期：2
• 页码：410-416
• 全文大小：464 KB
• 参考文献：1. Hollander, JL, Brown, EM, Jessar, RA, Brown, CY (1951) Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone a local anti-arthritic agent. J. Am. Med. Assoc. 147: pp. 1629-1635 CrossRef
  2. Snibbe, JC, Gambardella, RA (2005) Use for injections in osteoarthritis in joints and sports activity. Clin. Sports Med. 24: pp. 83-91 CrossRef
  3. Caldwell, JR (1996) Intra-articular corticosteroids. Guide for selection and indications for use. Drugs 52: pp. 507-514 CrossRef
  4. Cheng, OT, Souzdalnitski, D, Vrooman, B, Cheng, J (2012) Evidence based knee injections for the management of arthritis. Pain. Med. 13: pp. 740-753 CrossRef
  5. Neustadt, DH (2006) Intra-articular injections for osteoarthritis of the knee. Clev. Clin. Journ. Med. 73: pp. 897-911 CrossRef
  6. Hochberg, MC, Perlmutter, DL, Hudson, JL, Altman, RD (1996) Preferences in the management of osteoarthritis of the hip and knee:results of a survey of community based rheumatologist in the United States. Arthritis Care Res. 9: pp. 170-176 CrossRef
  7. Habib, GS (2009) Systemic effects of intra-articular corticosteroids. Clin. Rheumatol. 28: pp. 749-756 CrossRef
  8. Berthelot, JM, Goff, B, Maugars, Y (2013) Side effects of corticosteroid injections:whats new?. Joint Bone Spine 80: pp. 363-367 CrossRef
  9. Pekarek, B, Osher, L, Buck, S, Bowen, M (2011) Intra-articular corticosteroid injections: a critical literature review with up-to-date findings. The Foot 21: pp. 66-70 CrossRef
  10. Cole, BJ, Schumacher, HR (2005) Injectable corticosteroids in modern practices. J. Am. Acad. Ortho. Surg. 13: pp. 37-46
  11. Ringold, S, Weiss, PF, Beukelman, T, Dewitt, EM, Llowite, NT, Kimura, Y, Laxer, RM, Lovell, DJ, Nigrovic, PA, Robinson, AB, Vehe, RK (2013) 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res. 65: pp. 1551-1563 CrossRef
  12. Arroll, B, Goodyear-Smith, F (2004) Corticosteroid injections for osteoarthritis of the knee:meta-analysis. BMJ 328: pp. 869 CrossRef
  13. Scott, DL, Shipley, M, Dawson, A, Edwards, S, Symmons, DP, Woolf, AD (1998) The clinical management of rheumatoid arthritis and osteoarthritis:strategies for improving clinical effectiveness. Br. J. Rheumatol. 37: pp. 546-554 CrossRef
  14. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee (non-arthroplasty). Full guidance www.aaos.org/research/guidelines/OAKguideline.PDF; Dec 2008
  15. Cleary, AG, Murphy, HD, Davidson, JE (2003) Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch. Dis. Child. 88: pp. 192-196 CrossRef
  16. Bellamy, N, Campbell, J, Robinson, V, Gee, T, Bourne, R, Wells, G (2006) Intra-articular corticosteroid for treatment of osteoarthritis of the knee. Coch. Data. Syst. Rev. 19: pp. CD005328
  17. Stephens, MB, Beutler, AI, O’Connor, FG (2008) Musculoskeletal injections: a review of the evidence. Am. Fam. Physician 78: pp. 971-976
  18. Lavelle
• 刊物主题：Endocrinology; Diabetes; Internal Medicine; Science, general;
• 出版者：Springer US
• ISSN：1559-0100

文摘

The use of intra-articular (IA) glucocorticoids for reducing pain and inflammation in patients with osteoarthritis, rheumatoid arthritis, and other inflammatory arthropathies is widespread among primary care physicians, specialists, and non-specialists in the United States. Injectable glucocorticoids have anti-inflammatory and analgesic properties which can be effective in improving clinical parameters such as pain, range of motion, and quality of life. After injection into the IA space, glucocorticoids may be systemically absorbed; the degree of absorption can depend on the size of the joint injected, the injectable glucocorticoid preparation used, the dosage, and the frequency of the injection. The adverse effects of intra-articular glucocorticoid injections (IAGC) can often be overlooked by both the patient and physicians who administer them, in particular the potential deleterious effect on the hypothalamic–pituitary?adrenal (HPA)-axis which can result in adrenal suppression and/or iatrogenic Cushing syndrome. In this paper we provide an overview on the often under-recognized effects of IAGC on HPA-axis function.